Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion
about
Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeatsThe disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrinsThe cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreadingSyndecan-regulated receptor signalingADAM15 disintegrin is associated with aggressive prostate and breast cancer diseaseADAM metalloproteases and EGFR signallingSyndecans in tumor cell adhesion and signalingDirect interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cellsADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasisMeltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src.Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells.Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implicationsThe disulfide bond pattern of catrocollastatin C, a disintegrin-like/cysteine-rich protein isolated from Crotalus atrox venom.ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.DNA methylation in the tumor microenvironment.ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.The expression of ADAM12 (meltrin alpha) in human giant cell tumours of boneThe role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.Cloning of a salivary gland metalloprotease and characterization of gelatinase and fibrin(ogen)lytic activities in the saliva of the Lyme disease tick vector Ixodes scapularisIntracellular processing of metalloprotease disintegrin ADAM12.Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12Variability in melanoma metalloproteinase expression profilingProprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.Alternative mRNA splicing generates two distinct ADAM12 prodomain variants.Analysis of single nucleotide polymorphisms within ADAM12 and risk of knee osteoarthritis in a Chinese Han population.ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factorExtracellular proteases as targets for drug developmentAdvances in urinary protein biomarkers for urogenital and non-urogenital pathologies.ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site.Membrane associated proteases and their inhibitors in tumour angiogenesis.ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.ADAM12 induces estrogen-independence in breast cancer cells.Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine.
P2860
Q24291052-8746AC3C-885A-4BAF-9B89-2D1515AAE5EBQ24303582-9350F3D0-BE96-49EE-8124-AF1D96DEDF4FQ24669779-DE28E73F-CC40-46FB-BEA6-D64D4DB63C43Q24669899-2F49B346-2639-47DD-BD54-2CB3BBB1C1ECQ24676359-9C3FD89E-ECFA-4379-80D6-02D3A02F6052Q24803587-1744B39A-9E86-44B3-B77E-97AD8619678DQ24807364-8D91F5E9-FF05-4E8E-9202-F05AA0247701Q28213611-284EC21C-042D-45D8-9370-2A0E6FE2980BQ28264390-B2D6FD32-E350-49E2-B97F-801C0120D09EQ30168554-02B1263C-5430-4F70-B054-12B440F81006Q30168591-EBB79AA3-248D-40DE-A3F9-CDE188EA16BAQ30360467-AFF80E21-D54A-48F1-9FCD-C2059F0E8162Q30430629-22CA6836-609A-4A46-8355-C582EEAFB8B8Q30444013-B7071832-4300-4B85-9613-9524406A4E48Q31148772-013798C6-FDA2-44CE-9B82-318D4E0FAEA7Q33346972-E61616AD-A123-40A1-9B18-FEE0E65BE49CQ33351256-03102111-331E-4B34-B062-E2472F8319DFQ33722994-42D93978-E666-44B5-96AC-A6CD95E762A0Q33763885-3F3C72E7-4AAB-479F-AA8D-3A5678BB332AQ33860861-FF529823-1320-4541-AAB3-599752D25918Q33919104-0C85B1DD-F80D-4FD3-880F-8D130DDE7D26Q33991229-C18E2284-3351-4A86-909E-39F9BDB522BAQ33993583-1B6C0E34-31D4-433E-B650-6DA5BC2EBAC5Q34127626-699383BB-F238-4165-A924-8AB2753F98EFQ34291116-F8F30EF4-386E-42D4-99B4-63F74907CAD2Q34296399-A1AAFB4F-8A9C-4697-8268-1555C5EF6589Q34679398-3A185B56-52B2-4796-99EA-D2D0A14E5367Q34769647-292D08DD-9C9F-4C95-94D9-E524D727C52BQ35014541-693C9178-B2C4-40D0-ADF0-0FB27CCBC065Q35033870-BE3E06E2-7F20-4B16-9DB1-768688BA21C1Q35103401-0A7AABBE-CC84-409E-9B6F-B0F33C98B910Q35116202-A0FB1CB7-38D6-42A5-BF62-620F74F42FACQ35460015-76648FB8-6D97-4519-A52C-D6329B0D1503Q35560725-66A414C4-6871-45CA-A741-688DFD34AE41Q35583121-18D6CBC9-FB93-48E2-B523-7ABCF896BF97Q35587684-6B583E20-0565-4EEF-907D-C1ABB1BCA1ADQ35747862-0DA65DA2-7CB6-475F-A24F-CA8ADCF855E7Q35788620-9BD20B30-E4AF-462A-AE60-93E7ED9AE3D5Q36054273-7098CC4A-7DE2-4409-830C-9AD115DA8CCCQ36226867-CBE5541B-7E79-4F3F-BDFC-4DECC32F4A99
P2860
Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion
@en
Cysteine-rich domain of human ADAM 12
@nl
type
label
Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion
@en
Cysteine-rich domain of human ADAM 12
@nl
prefLabel
Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion
@en
Cysteine-rich domain of human ADAM 12
@nl
P2093
P2860
P1476
Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65403-X
P407
P577
1999-05-01T00:00:00Z